SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-212188
Filing Date
2011-08-05
Accepted
2011-08-05 15:21:01
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 418694
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9713
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9713
4 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4634
  Complete submission text file 0001193125-11-212188.txt   1556925

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT agen-20110630.xml EX-101.INS 142475
6 XBRL TAXONOMY EXTENSION SCHEMA agen-20110630.xsd EX-101.SCH 11530
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agen-20110630_cal.xml EX-101.CAL 37342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agen-20110630_def.xml EX-101.DEF 26844
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20110630_lab.xml EX-101.LAB 116649
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20110630_pre.xml EX-101.PRE 81215
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 111014042
SIC: 2836 Biological Products, (No Diagnostic Substances)